|
Match
|
Document |
Document Title |
|
|
US20090280171 |
METHOD OF TREATMENT WITH PREDICTABLY BREAKABLE PHARMACEUTICAL TABLETS
The invention involves the use of finished dosage forms, e.g., tablets, by breaking or otherwise dividing them to produce a predictably accurate smaller or lower dose.
|
|
|
US20090274756 |
Stabilized composition
It is intended to provide a pharmaceutical composition which contains a proton pump inhibitor and is stable even if it is stored for a long time. It is also intended to provide a pharmaceutical...
|
|
|
US20090269400 |
Nanoparticulate and Controlled Release Compositions Comprising a Cephalosporin
The present invention is directed to compositions comprising a nanoparticulate antibiotic having improved bioavailability. Preferably, the antibiotic comprises nanoparticulate cephalosporin...
|
|
|
US20090252791 |
PHARMACEUTICAL COMPOSITIONS COMPRISING A TRIPTAN AND A NONSTEROIDAL ANTI-INFLAMMATORY DRUG
Dosage forms for administering a triptan and a nonsteroidal anti-inflammatory drug are disclosed, including multilayered tablets and mini-tablets. These multilayered tablets can be in a...
|
|
|
US20090252790 |
TABLET FORMULATION
The present invention relates to a pharmaceutical fixed dose combination tablet comprising repaglinide and metformin. The present invention also provides a method of producing said tablet.
|
|
|
US20090246275 |
Compositions and methods for delivery of embolics
Described herein are compositions comprising one or more embolics attached to an inert, dissolvable matrix as well as kits comprising these novel embolic formulations. Also described are methods of...
|
|
|
US20090246256 |
Compositions and Methods for Transmucosal Delivery of Lofexidine
The present invention provides for compositions and methods for accelerating the rate of delivery of lofexidine to the systemic circulation by transmucosal administration through the nasal,...
|
|
|
US20090238867 |
Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
Nanoparticulate compositions comprising anidulafungin are described, as well as methods of making such compositions. Also described are methods for treatment of fungal infections.
|
|
|
US20090232858 |
METHOD AND PROCESS FOR THE PRODUCTION OF MULTI-COATED RECOGNITIVE AND RELEASING SYSTEMS
The present invention includes compositions, methods, systems for the controlled delivery of an active agent in a tablet polymer comprising two or more layers, wherein each of the two or more...
|
|
|
US20090226514 |
Compressed
The invention provides a compressed tablet including a volatile active agent, preferably menthol, within a spray-dried granule further comprising a starch carrier and, optionally, a polyol...
|
|
|
US20090220596 |
Composition and Dosage Form Comprising a Solid or Semi-Solid Matrix
A composition which comprises a solid or semi-solid matrix having at least one active ingredient uniformly dispersed therein, the matrix comprising at least one pharmaceutically acceptable...
|
|
|
US20090202635 |
Delivery System, Application, and Method
A sequenced biologically compatible delivery system, application, and method is provided, which increases therapeutic care of animals by conveniently and effectively supplying meticulous...
|
|
|
US20090202634 |
PHARMACEUTICAL DOSAGE FORM
The invention relates to a pharmaceutical dosage form, preferably with controlled release of a pharmacologically active compound (A) contained therein, the pharmaceutical dosage form very...
|
|
|
US20090202631 |
METHODS AND DOSAGE FORMS FOR CONTROLLED DELIVERY OF PALIPERIDONE AND RISPERIDONE
Dosage forms and methods for providing a substantially ascending rate of release of paliperidone or risperidone are provided. The sustained release dosage forms provide therapeutically effective...
|
|
|
US20090202630 |
ORALLY DISINTEGRATING TABLET COMPOSITIONS OF RANITIDINE AND METHODS OF MANUFACTURE
The present invention is directed to pharmaceutical compositions comprising taste-masked microcapsules comprising ranitidine, orally disintegrating tablets comprising such compositions, and methods...
|
|
|
US20090202628 |
Nanoparticles for protein drug delivery
The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one protein drug or bioactive agent characterized with a positive surface charge and their enhanced...
|
|
|
US20090191217 |
Anti-IL-1R1 Single Domain Antibodies And Therapeutic Uses
Disclosed is the use of an antagonist of Interleukin 1 receptor type 1 (IL-1R1) for the manufacture of a medicament treating, preventing or suppressing lung inflammation or a respiratory disease....
|
|
|
US20090186081 |
Disintegrating Loadable Tablets
A disintegrating loadable tablet product in compressed form comprising i) at least 60% w/w of a sorbent material having a specific surface area (BET surface area) of at least 50 m2/g as measured by...
|
|
|
US20090181083 |
Porous tablets as carriers for liquid formulations
A novel tablet product that in an easy, flexible and reproducible manner can be loaded with a relatively high amount of a pharmaceutically acceptable liquid formulation e.g. carrying a...
|
|
|
US20090181082 |
TABLET
The present invention can retain the volume of a tablet large without increasing the thickness of the tablet or the like dimension and prevents a plurality of tablets from sticking to each other...
|
|
|
US20090175939 |
PHARMACEUTICAL COMPOSITIONS
Methods and compositions are provided which comprise effective amounts of analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
|
|
|
US20090175936 |
Microtablet-Based Pharmaceutical Preparation
A pharmaceutical preparation consisting of various microtablets containing ingredients. The microtablets have the same form and the same weight.
|
|
|
US20090169620 |
ORALLY DISINTEGRATING TABLET COMPOSITIONS OF TEMAZEPAM
The compositions of the present invention are orally disintegrating tablet compositions comprising a therapeutically effective amount of at least one drug such as temazepam, 0.5-3% of an ODT binder...
|
|
|
US20090162435 |
MANUFACTURE OF TABLET
The present invention features a method of manufacturing a tablet containing a pharmaceutically active agent by the steps of: (a) adding a powder containing a pharmaceutically-acceptable carrier to...
|
|
|
US20090162428 |
Immediate disintegration polyvalent polymeric matrix for modified release solid oral preparations and method of preparation thereof
An immediate disintegrating polymeric matrix for oral administration with modified release is disclosed, obtained without using inert supports such as sugar spheres, comprising particles of active...
|
|
|
US20090155361 |
TABLET WITH MULTIPLE DRUG-CONTAINING SECTIONS
A tablet which is either a two-layer tablet comprising a layer A and a layer B or a three-layer tablet comprising a layer A, a layer B and a layer C in that order, wherein the layer B is a...
|
|
|
US20090155360 |
ORALLY DISINTEGRATING TABLETS COMPRISING DIPHENHYDRAMINE
The compositions of the present invention comprise a therapeutically effective amount of particles consisting of diphenhydramine or pharmaceutically acceptable salts thereof, optionally in...
|
|
|
US20090155359 |
GRANULATED PARTICLES, TABLETS AND METHOD FOR PRODUCING GRANULATED PARTICLES
The present invention relates to granulated particles including a poorly water soluble drug (A) and a diluent (B) and characterized in that a volume average particle size of the particles of the...
|
|
|
US20090155351 |
Solid Vaccine Formulation
The invention relates to a solid vaccine formulation adapted for mucosal administration comprising at least one antigen as active substance, wherein the formulation comprises a lyophilisate of a...
|
|
|
US20090148521 |
SOLID ORAL FORM OF A MEDICINAL PREPARATION AND A METHOD FOR THE PRODUCTION THEREOF
A solid oral form of an antibody-based medicinal preparation comprises an effective carrier quantity irrigated with an active form of an antibody aqueous-alcoholic dilution, which is prepared by...
|
|
|
US20090148520 |
TABLET
The present invention can inhibit the occurrence of defective products without increasing the hardness of a tablet even if stress is applied to the tablet on transporting it or packing it by an...
|
|
|
US20090148512 |
NOVEL USES OF CHLORAMPHENICOL AND ANALOGOUS THEREOF
A method for reducing the resistance of an MRSA bacterium to an antibiotic selected from the group consisting of vancomycin and methicillin comprising administering to a patient in need thereof an...
|
|
|
US20090142393 |
Stable Compositions of Famotidine and Ibuprofen
Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface...
|
|
|
US20090142392 |
Composition Comprising a NSAID and Paracetamol
A process for producing a granular composition comprising a plurality of solidified melt granules including a non-steroidal anti-inflammatory drug (NSAID) and paracetamol (acetaminophen), the...
|
|
|
US20090136569 |
Rapidly disintergrating tablet in oral cavity
The present invention provides a method of suppressing the bitter taste of a drug when a rapidly disintegrating tablet in an oral cavity is produced. When a rapidly disintegrating tablet in an...
|
|
|
US20090136568 |
Tabletting process
A process for producing a compressed solid dosage form containing an active ingredient. The process includes a step of preparing core elements containing the active ingredient. Optionally the core...
|
|
|
US20090130205 |
Solid Pharmaceutical Composition Comprising Donepezil Hydrochloride
The invention relates to a solid pharmaceutical composition comprising donepezil hydrochloride hydrate and a process for its preparation. In particular it relates to a composition and a process...
|
|
|
US20090130196 |
Bacteriophage composition
Bacteriophage compositions, and methods for preparing bacteriophage compositions are provided. The method for producing an antibacterial composition involves adsorbing an aqueous solution of one or...
|
|
|
US20090123540 |
Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof
A particulate SAE-CD composition is provided. The SAE-CD composition has an advantageous combination of physical properties not found in known solid forms of SAECD. In particular, the SAE-CD...
|
|
|
US20090123539 |
WET GRANULATION USING A WATER SEQUESTERING AGENT
Disclosed are tablets comprising hydrolytically stable formulations of (6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)...
|
|
|
US20090123538 |
Angiotensin II Receptor Antagonists
The compounds of the present invention are polymorphic crystalline forms of the compound 2-butyl-4-chloro-1-[(2′-(1-H-tetrazol-5-yl)biphenyl-4-yl)m
ethyl]-imidazole-5-carboxylic acid, which has...
|
|
|
US20090117182 |
INTRAORALLY RAPIDLY DISINTEGRATING TABLET
The present invention provides an intraorally rapidly disintegrating tablet that can be formed using an ordinary apparatus, that has hardness with no practical problem and that disintegrates...
|
|
|
US20090117181 |
Tablet comprising fluvastatin and carmellose calcium
The present invention relates to a fluvastatin-containing tablet, particularly a fluvastatin-containing tablet which has excellent disintegrating property and good bioavailability.
|
|
|
US20090104263 |
5-HT4 partial agonist pharmaceutical compositions
A solid pharmaceutical composition for oral administration comprising tegaserod in base or salt form in an amount of up to 10% by weight a bulking agent in an amount of 70 to 90% by weight a...
|
|
|
US20090104262 |
Chlorthalidone combinations
The invention relates to favourable combinations of the thiazide diuretic chlorthalidone with Angiotensin II Receptor Blockers (ARBs) for the treatment of hypertension.
|
|
|
US20090098199 |
METHODS OF TREATING GASTROINTESTINAL DISORDERS INDEPENDENT OF THE INTAKE OF FOOD
The present invention relates to a method of treating a gastrointestinal disorder by administering to a patient in need of treatment thereof a pharmaceutical composition, wherein said...
|
|
|
US20090092670 |
LONG ACTING DUAL RELEASE PRODUCT CONTAINING CARBINOXAMINE AND PSEUDOEPHEDRINE
Provided are oral dosage forms that contain carbinoxamine in an immediate release format, and pseudoephedrine in a prolonged release format. The biphasic oral dosage forms may also contain other...
|
|
|
US20090092658 |
NOVEL FORMULATIONS OF PROTON PUMP INHIBITORS AND METHODS OF USING THESE FORMULATIONS
The present invention relates to combinations of a proton pump inhibiting agent and at least one buffering agent that have been found to possess improved bioavailability, chemical stability,...
|
|
|
US20090087485 |
Orally Disintegrating Tablets
The present invention describes a directly compressible composite excipient prepared by coating calcium silicate with a carbohydrate. The present invention further describes the incorporation of...
|
|
|
US20090081288 |
Orodispersible Domperidone Tablets
The present invention relates to an orodispersible tablet comprised of, by weight: a maximum of 15% of a low-dose, therapeutically active substance; from 55% to 70% of mannitol of a particle size...
|